Show simple item record

The risk of hepatotoxicity during long-term and low-dose flutamide treatment in hirsutism

dc.contributor.authorBalat, Ozcan
dc.contributor.authorPENÇE, Sadrettin
dc.contributor.authorAKÇALI, CENK
dc.contributor.authorÇİÇEK, HÜLYA
dc.contributor.authorDİKENSOY, EBRU
dc.date.accessioned2021-03-05T10:11:56Z
dc.date.available2021-03-05T10:11:56Z
dc.date.issued2009
dc.identifier.citationDİKENSOY E., Balat O., PENÇE S., AKÇALI C., ÇİÇEK H., "The risk of hepatotoxicity during long-term and low-dose flutamide treatment in hirsutism", ARCHIVES OF GYNECOLOGY AND OBSTETRICS, cilt.279, ss.321-327, 2009
dc.identifier.issn0932-0067
dc.identifier.otherav_a1e17490-6d49-4aac-ae7d-d897525659ce
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/108443
dc.identifier.urihttps://doi.org/10.1007/s00404-008-0719-z
dc.description.abstractFlutamide is an effective drug in treatment of hirsutism. Hepatotoxicity occasionally may occur with therapeutic doses (750-1500 mg/day), 3 months after initiation of treatment. Monitoring of serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels is recommended to obviate serious hepatotoxicity.
dc.language.isoeng
dc.subjectKadın Hastalıkları ve Doğum
dc.subjectCerrahi Tıp Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectKADIN HASTALIKLARI & DOĞUM
dc.titleThe risk of hepatotoxicity during long-term and low-dose flutamide treatment in hirsutism
dc.typeMakale
dc.relation.journalARCHIVES OF GYNECOLOGY AND OBSTETRICS
dc.contributor.departmentGaziantep Üniversitesi , ,
dc.identifier.volume279
dc.identifier.issue3
dc.identifier.startpage321
dc.identifier.endpage327
dc.contributor.firstauthorID589938


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record